既往非卵巢癌患者CT偶然发现附件病变的恶性预测因素
本研究回顾性分析276例既往非卵巢癌女性患者的门静脉期增强CT,评估偶然发现的附件病变的影像特征与恶性结局的关系。多因素分析显示病变大小>5 cm、双侧性、形态不规则、衰减高于单纯液体、成分不均匀与恶性显著相关,基于这五个特征的点数系统预测恶性AUC为0.97。
要点
- 既往非卵巢癌患者偶然附件病变,若出现>5 cm、双侧、不规则、高衰减、不均匀等特征需警惕恶性。
- 无上述恶性特征时恶性风险为0%,出现3个及以上特征时恶性风险达100%。
- 门静脉期增强CT可用于评估附件病变恶性风险,辅助临床决策。
关键影像表现/征象
- 病变大小>5 cm与恶性相关(P=0.01,OR=9.11,95%CI 1.70-48.87)。
- 双侧性与恶性相关(P<0.0001,OR=28.34,95%CI 7.46-107.67)。
- 形态不规则与恶性相关(P=0.01,OR=12.31,95%CI 1.61-94.05)。
- 衰减高于单纯液体与恶性相关(P<0.0001,OR=28.27,95%CI 5.65-141.59)。
- 成分不均匀与恶性相关(P=0.0017,OR=10.75,95%CI 2.45-47.23)。
诊断标准与关键数值
- 五特征逻辑回归模型预测恶性AUC为0.97。
- 基于五个特征的点数系统(0-5分)AUC为0.97。
- 无恶性特征时恶性率0%(0/147),1个特征时12.7%(8/63),2个特征时51.7%(15/29),3个及以上特征时100%(37/37)。
临床应用与阅片要点
- 阅片时对既往非卵巢癌患者的附件病变,应重点评估大小、侧别、形态、衰减和成分,并记录恶性特征数量。
- 无恶性特征者可考虑随访,出现3个及以上特征时高度提示恶性,需建议进一步检查或专科会诊。
- 注意门静脉期增强CT是评估基础,其他期相或平扫可能影响特征判断。
局限性
- 回顾性单中心研究,样本来自三级癌症中心,可能存在选择偏倚。
- 点系统为内部推导,未进行外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify imaging features in incidental adnexal lesions which are associated with malignancy on portal venous phase contrast-enhanced CT in patients with known non-ovarian cancer.
MATERIALS AND METHODS: This IRB-approved, HIPAA-compliant retrospective study was performed at a tertiary cancer center. Portal venous phase contrast-enhanced CT from January 2010 to December 2015 was reviewed to identify women with non-ovarian malignancy and incidental adnexal lesion, with mean 18 months (range 1-80 months) to definitive diagnosis or last imaging follow-up. Imaging features of adnexal lesions were recorded (size, laterality, shape, attenuation, and composition) and correlated with outcome (benign or malignant) using univariate and multivariate logistic regression analysis. A point-based system was used to predict likelihood of malignancy.
RESULTS: Of 276 women (mean age 45 years), 216 (78.3%) had benign lesions, 58 (21.0%) ovarian metastasis, and 2 (0.7%) had primary ovarian malignancy. On logistic regression model, lesion size > 5 cm (p-value, OR, 95% CI 0.01, 9.11, 1.70-48.87), bilaterality (< 0.0001, 28.34, 7.46-107.67), irregular shape (0.01, 12.31, 1.61-94.05), higher-than-simple-fluid attenuation (< 0.0001, 28.27, 5.65-141.59), and heterogeneous composition (0.0017, 10.75, 2.45-47.23) were associated with malignant outcome (AUC 0.97). A point-based system incorporating these five features (possible 0-5 points) had AUC of 0.97. Rate of malignancy was 0% (0/147) if none of the features of malignancy were present, 12.7% (8/63) if one feature was present, 51.7% (15/29) if two features were present, and 100% (37/37) if three or more features present.
CONCLUSION: Risk of malignancy of incidental adnexal lesions in women with prior non-ovarian cancer can be estimated based on lesion features seen on portal venous phase contrast-enhanced CT.
引用
- Shinagare AB, Gujrathi I, Cochon L, et al. Predictors of malignancy in incidental adnexal lesions identified on CT in patients with prior non-ovarian cancer. Abdom Radiol (NY). 2021. PMID: 34468797. doi:10.1007/s00261-021-03233-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。